Aether Industries Ltd
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]
- Market Cap ₹ 9,993 Cr.
- Current Price ₹ 754
- High / Low ₹ 938 / 725
- Stock P/E 54.3
- Book Value ₹ 168
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 7.80 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 4.49 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 8.44% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 590 | 651 | 598 | 839 | 915 | |
| 422 | 465 | 466 | 598 | 636 | |
| Operating Profit | 168 | 186 | 132 | 241 | 279 |
| OPM % | 28% | 29% | 22% | 29% | 30% |
| 7 | 17 | 25 | 30 | 21 | |
| Interest | 13 | 5 | 9 | 13 | 15 |
| Depreciation | 15 | 23 | 40 | 45 | 49 |
| Profit before tax | 146 | 174 | 110 | 213 | 235 |
| Tax % | 26% | 25% | 25% | 26% | |
| 109 | 130 | 82 | 158 | 176 | |
| EPS in Rs | 9.67 | 10.47 | 6.22 | 11.95 | 13.24 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -8% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 8% |
| Last Year: | 8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 113 | 125 | 133 | 133 |
| Reserves | 274 | 1,120 | 1,931 | 2,093 |
| 291 | 16 | 183 | 200 | |
| 92 | 120 | 154 | 218 | |
| Total Liabilities | 770 | 1,380 | 2,401 | 2,644 |
| 257 | 646 | 853 | 1,117 | |
| CWIP | 58 | 37 | 232 | 363 |
| Investments | 17 | 1 | 0 | 0 |
| 438 | 695 | 1,315 | 1,163 | |
| Total Assets | 770 | 1,380 | 2,401 | 2,644 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -5 | -7 | -16 | 100 | |
| -151 | -348 | -424 | -418 | |
| 169 | 439 | 894 | 2 | |
| Net Cash Flow | 12 | 84 | 453 | -316 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 101 | 145 | 142 | 126 |
| Inventory Days | 221 | 301 | 411 | 356 |
| Days Payable | 95 | 99 | 124 | 114 |
| Cash Conversion Cycle | 227 | 348 | 429 | 367 |
| Working Capital Days | 82 | 268 | 279 | 238 |
| ROCE % | 18% | 7% | 10% |
Documents
Announcements
-
Revised Intimation For Grant Of Employee Stock Options
16 Oct - 2,99,982 ESOPs granted at Rs.748; 50% vests 20-Oct-2027, 50% 20-Oct-2028; 3-year exercise period.
-
Intimation Of Grant Of Stock Options To Employees
16 Oct - Grant of 299,982 ESOPs at Rs.748; 50% vesting 20.10.2027, 50% vesting 20.10.2028.
-
Intimation Of The ESG Rating
7 Oct - CRISIL ESG 51 (Category: Adequate) for Aether Industries dated Sept 30, 2025.
-
Board Meeting Intimation for The Meeting Scheduled Oon Thursday, November 13, 2025
4 Oct - Board meeting on Nov 13, 2025 to approve unaudited Q2 and H1 results for Sept 30, 2025.
-
Announcement under Regulation 30 (LODR)-Credit Rating
30 Sep - ICRA assigns [ICRA]A+ (Positive) long-term and [ICRA]A1 short-term on Rs.296 crore; Sep 26, 2025.
Annual reports
Concalls
-
Jul 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Jan 2025Transcript PPT REC
-
Jan 2025TranscriptNotesPPT
-
Oct 2024Transcript PPT REC
-
Jul 2024TranscriptPPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Jul 2023Transcript PPT
-
Jun 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Jun 2022Transcript PPT
Business Segments FY24[1]
Large Scale Manufacturing (59%) Advanced intermediates and specialty chemicals with application across the industry spectrum.
Contract Manufacturing (26%)
Manufacture under contractual supply agreements with MNCs.
CRAMS (14%)
Contract research, scale-up services, technology development, low volume high-value contract manufacturing.